» Articles » PMID: 12067718

Identification of a CTL4/Neu1 Fusion Transcript in a Sialidosis Patient

Overview
Journal FEBS Lett
Specialty Biochemistry
Date 2002 Jun 18
PMID 12067718
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

The deficiency of the lysosomal neuraminidase (NEU1; sialidase) causes the storage disorder sialidosis with symptoms ranging from eye abnormalities and neurological disturbances to skeletal malformations, mental retardation and early death. Sialidosis patients encompassing a wide spectrum of clinical symptoms were screened for mutations in neu1. We identified the same homozygous interstitial deletion (11 kb) in two patients causing the fusion of exon 10 of CTL4 (New Gene 22; NG22) with the 3'-UTR of neu1. In one patient we found the resulting CTL4/Neu1 fusion transcript, in the other we detected an alternatively spliced CTL4 transcript (retention of intron 9).

Citing Articles

Genetic Insights into Therapeutic Targets for Neuromyelitis Optica Spectrum Disorders: A Mendelian Randomization Study.

Cao Y, Zhang J, Wang J Mol Neurobiol. 2024; .

PMID: 39565569 DOI: 10.1007/s12035-024-04612-8.


NEU1-A Unique Therapeutic Target for Alzheimer's Disease.

Khan A, Sergi C Front Pharmacol. 2022; 13:902259.

PMID: 35847014 PMC: 9277458. DOI: 10.3389/fphar.2022.902259.


Therapeutic Potential of Neu1 in Alzheimer's Disease Via the Immune System.

Khan A, Das S, Sergi C Am J Alzheimers Dis Other Demen. 2021; 36:1533317521996147.

PMID: 33719595 PMC: 10624071. DOI: 10.1177/1533317521996147.


Identification of a homozygous deletion of the NEU1 gene in a patient with type II sialidosis presenting isolated fetal ascites and central nervous system hypoplasia.

Mitsiakos G, Gialamprinou D, Chouchou P, Chatziioannidis I, Karagianni P Hippokratia. 2020; 23(4):169-171.

PMID: 32742167 PMC: 7377589.


The best evidence for progressive myoclonic epilepsy: A pathway to precision therapy.

Orsini A, Valetto A, Bertini V, Esposito M, Carli N, Minassian B Seizure. 2019; 71:247-257.

PMID: 31476531 PMC: 7288863. DOI: 10.1016/j.seizure.2019.08.012.